Cengild Medical Bhd (XKLS:0243) Total Stockholders Equity: RM115.87 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0243 Cengild Medical Bhd XKLS:0243
63 GF Score
Price RM0.19
GF Value RM0.29
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cengild Medical Bhd Total Stockholders Equity?

Cengild Medical Bhd XKLS:0243 -2.56% 63 Total Stockholders Equity is RM115.87 Mil as of Mar. 2026. GuruFocus rates XKLS:0243 with a GF Score™ of 63/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Cengild Medical Bhd's Total Stockholders Equity for the quarter that ended in Mar. 2026 was RM115.87 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cengild Medical Bhd's Book Value per Share for the quarter that ended in Mar. 2026 was RM0.14. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cengild Medical Bhd's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.75.

Cengild Medical Bhd  (XKLS:0243) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cengild Medical Bhd's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(115.872-0)/832.913
=0.14

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cengild Medical Bhd's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(2.41 + 84.12) / 115.872
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cengild Medical Bhd Total Stockholders Equity Related Terms

Cengild Medical Bhd Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cengild Medical Bhd's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cengild Medical Bhd Total Stockholders Equity Chart

Cengild Medical Bhd Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Stockholders Equity
Get a 7-Day Free Trial 13.78 92.95 106.11 111.30 114.46

Cengild Medical Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.21 114.46 114.31 116.98 115.87
XKLS:0243
63GF Score
Cengild Medical Bhd XKLS:0243
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of RM115.87 Mil mean?
Cengild Medical Bhd (XKLS:0243) has a Total Stockholders Equity of RM115.87 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cengild Medical Bhd and its competitors.
Is Cengild Medical Bhd's Total Stockholders Equity too high?
Cengild Medical Bhd's current Total Stockholders Equity is RM115.87 Mil. Overall, Cengild Medical Bhd has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Total Stockholders Equity compare to HCA and THC?
Cengild Medical Bhd's Total Stockholders Equity of RM115.87 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current Total Stockholders Equity is RM115.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.19 — trading 34.5% below its estimated fair value. The current Total Stockholders Equity is RM115.87 Mil. Cengild Medical Bhd's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Total Stockholders Equity is RM115.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?

Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued. The current stock price of RM0.19 is trading 34.5% below its estimated GF Value™ of RM0.29. GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.

Key valuation signals for XKLS:0243:

  • Total Stockholders Equity: RM115.87 Mil
  • GF Value™: RM0.29 vs. price of RM0.19 (34.5% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cengild Medical Bhd Business Description

Address No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
63GF Score

Get the complete analysis for XKLS:0243

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.19
Price
RM0.29
GF Value